Frontlight ResearchEarly access
Trial site
Hôpital Universitaire Dupuytren
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Phase
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Groupe Francophone des Myelodysplasies1 trial
- Inotrem1 trial
- Institut Curie1 trial
- UNICANCER1 trial
Running trials
Not yet recruiting
Analysis of histological risk factors and biomarkers in paediatric retinoblastoma
Active, not recruiting
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
Active, not recruiting
Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026